Ajanta Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 1,031.87 | 1,135.15 | 1,169.25 |
| Operating Expense | 764.29 | 765.59 | 826 |
| Net Profit | 193.43 | 252.45 | 234.98 |
| Net Profit Margin | 18.75 | 22.24 | 20.10 |
| Earning Per Share | 15.46 | 20.16 | 18.75 |
| EBIDTA | 271.96 | 366.24 | 340.16 |
| Effective Tax Rate | 14.61 | 20.67 | 20.72 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 1031.87 |
| Operating Expense | 764.29 |
| Net Profit | 193.43 |
| Net Profit Margin | 18.75 |
| Earning Per Share | 15.46 |
| EBIDTA | 271.96 |
| Effective Tax Rate | 14.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 4,322.04 | 3,971.12 | 3,411.27 |
| Operating Expenses Annual | 3,117.32 | 2,851.69 | 2,711.99 |
| Operating Profit Annual | 1,324.59 | 1,235.91 | 832.03 |
| Interest Annual | 4.60 | 6.80 | 5.23 |
| Depreciation | 132.79 | 128.28 | 123.90 |
| Net Profit Annual | 916.89 | 807.24 | 558.72 |
| Tax Annual | 263.17 | 289.71 | 141.13 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 4,322.04 |
| Operating Expenses Annual | 3,117.32 |
| Operating Profit Annual | 1,324.59 |
| Interest Annual | 4.60 |
| Depreciation | 132.79 |
| Net Profit Annual | 916.89 |
| Tax Annual | 263.17 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 61.78 | 268.85 | 139.83 |
| Cash Flow from Operations | 1,053.80 | 735.35 | 736.29 |
| Cash Flow from Investing | -349.60 | 105.02 | -501.31 |
| Cash Flow from Financing | -715.71 | -1,047.70 | -105.12 |
| Cash Flow at the End | 50.27 | 61.52 | 269.69 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 61.78 |
| Cash Flow from Operations | 1,053.80 |
| Cash Flow from Investing | -349.60 |
| Cash Flow from Financing | -715.71 |
| Cash Flow at the End | 50.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 30.65 | 31.12 | 24.39 |
| PBIT Margin (%) | 27.41 | 27.79 | 20.67 |
| PBT Margin (%) | 21.45 | 23.70 | 16.72 |
| Net PROFIT Margin (%) | 21.21 | 20.33 | 16.38 |
| Return On Networth / Equity (%) | 26.05 | 24.24 | 17.42 |
| Return On Networth /Employed (%) | 32.78 | 32.49 | 21.63 |
| Return On Assets (%) | 25.46 | 23.78 | 17.20 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 1.20 | 1.17 | 1.05 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 30.65 |
| PBIT Margin (%) | 27.41 |
| PBT Margin (%) | 21.45 |
| Net PROFIT Margin (%) | 21.21 |
| Return On Networth / Equity (%) | 26.05 |
| Return On Networth /Employed (%) | 32.78 |
| Return On Assets (%) | 25.46 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 1.20 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1,741.96 | 1,464.89 | 1,484.01 |
| Total Current Assets Annual | 2,576.06 | 2,441.67 | 2,551.19 |
| Non Current Assets Annual | 1,978.19 | 1,775.77 | 1,753.60 |
| Total Shareholders Funds Annual | 3,625.31 | 3,413.57 | 3,246.45 |
| Total Assets Annual | 4,554.25 | 4,217.44 | 4,304.79 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1,741.96 |
| Total Current Assets Annual | 2,576.06 |
| Non Current Assets Annual | 1,978.19 |
| Total Shareholders Funds Annual | 3,625.31 |
| Total Assets Annual | 4,554.25 |
EPS (INR)
Expected
17.97
Reported
18.00
Surprise
0.17%
Dec 2024
EPS beaten by 0.17%
Sep 2024
EPS beaten by 0.11%
Jun 2024
EPS beaten by 0.00%
